rs6748672

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032601.4(MCEE):​c.311G>T​(p.Arg104Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 1,613,596 control chromosomes in the GnomAD database, including 25,168 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R104H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.18 ( 2680 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22488 hom. )

Consequence

MCEE
NM_032601.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.801

Publications

27 publications found
Variant links:
Genes affected
MCEE (HGNC:16732): (methylmalonyl-CoA epimerase) The product of this gene catalyzes the interconversion of D- and L-methylmalonyl-CoA during the degradation of branched chain amino acids. odd chain-length fatty acids, and other metabolites. Mutations in this gene result in methylmalonyl-CoA epimerase deficiency, which is presented as mild to moderate methylmalonic aciduria. [provided by RefSeq, Jul 2008]
MCEE Gene-Disease associations (from GenCC):
  • methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028464198).
BP6
Variant 2-71124273-C-A is Benign according to our data. Variant chr2-71124273-C-A is described in ClinVar as Benign. ClinVar VariationId is 138183.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MCEENM_032601.4 linkc.311G>T p.Arg104Leu missense_variant Exon 2 of 3 ENST00000244217.6 NP_115990.3 Q96PE7
MCEEXM_047446039.1 linkc.311G>T p.Arg104Leu missense_variant Exon 2 of 3 XP_047301995.1
MCEEXM_005264613.3 linkc.216+95G>T intron_variant Intron 2 of 2 XP_005264670.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MCEEENST00000244217.6 linkc.311G>T p.Arg104Leu missense_variant Exon 2 of 3 1 NM_032601.4 ENSP00000244217.5 Q96PE7
MCEEENST00000486135.1 linkc.26G>T p.Arg9Leu missense_variant Exon 3 of 3 3 ENSP00000441569.1 F5GZ54
MCEEENST00000494660.6 linkc.26G>T p.Arg9Leu missense_variant Exon 2 of 2 2 ENSP00000437361.1 F5GZ54
MCEEENST00000413592.5 linkc.84+95G>T intron_variant Intron 1 of 1 2 ENSP00000391140.1 H7BZS7

Frequencies

GnomAD3 genomes
AF:
0.182
AC:
27671
AN:
152066
Hom.:
2675
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.221
Gnomad AMI
AF:
0.211
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.207
Gnomad FIN
AF:
0.0917
Gnomad MID
AF:
0.153
Gnomad NFE
AF:
0.170
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.171
AC:
43015
AN:
251120
AF XY:
0.173
show subpopulations
Gnomad AFR exome
AF:
0.225
Gnomad AMR exome
AF:
0.173
Gnomad ASJ exome
AF:
0.158
Gnomad EAS exome
AF:
0.179
Gnomad FIN exome
AF:
0.0954
Gnomad NFE exome
AF:
0.169
Gnomad OTH exome
AF:
0.172
GnomAD4 exome
AF:
0.172
AC:
252075
AN:
1461412
Hom.:
22488
Cov.:
33
AF XY:
0.173
AC XY:
125908
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.219
AC:
7330
AN:
33472
American (AMR)
AF:
0.177
AC:
7922
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.159
AC:
4168
AN:
26132
East Asian (EAS)
AF:
0.217
AC:
8618
AN:
39698
South Asian (SAS)
AF:
0.204
AC:
17633
AN:
86248
European-Finnish (FIN)
AF:
0.0994
AC:
5309
AN:
53402
Middle Eastern (MID)
AF:
0.186
AC:
1071
AN:
5768
European-Non Finnish (NFE)
AF:
0.170
AC:
189378
AN:
1111594
Other (OTH)
AF:
0.176
AC:
10646
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
10786
21573
32359
43146
53932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6836
13672
20508
27344
34180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.182
AC:
27690
AN:
152184
Hom.:
2680
Cov.:
33
AF XY:
0.178
AC XY:
13259
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.221
AC:
9158
AN:
41512
American (AMR)
AF:
0.178
AC:
2728
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
568
AN:
3472
East Asian (EAS)
AF:
0.199
AC:
1029
AN:
5180
South Asian (SAS)
AF:
0.207
AC:
996
AN:
4816
European-Finnish (FIN)
AF:
0.0917
AC:
972
AN:
10594
Middle Eastern (MID)
AF:
0.154
AC:
45
AN:
292
European-Non Finnish (NFE)
AF:
0.170
AC:
11589
AN:
68000
Other (OTH)
AF:
0.195
AC:
413
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1163
2326
3490
4653
5816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
310
620
930
1240
1550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
8290
Bravo
AF:
0.188
TwinsUK
AF:
0.170
AC:
632
ALSPAC
AF:
0.177
AC:
681
ESP6500AA
AF:
0.228
AC:
1003
ESP6500EA
AF:
0.168
AC:
1449
ExAC
AF:
0.174
AC:
21100
EpiCase
AF:
0.174
EpiControl
AF:
0.177

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency Benign:3
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 17% of total chromosomes in ExAC -

Aug 26, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
8.9
DANN
Benign
0.97
DEOGEN2
Benign
0.27
T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.33
N
LIST_S2
Uncertain
0.97
D;.;D
MetaRNN
Benign
0.0028
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.46
N;.;.
PhyloP100
0.80
PrimateAI
Benign
0.27
T
PROVEAN
Uncertain
-2.5
D;N;N
REVEL
Benign
0.088
Sift
Uncertain
0.024
D;D;D
Sift4G
Uncertain
0.035
D;D;D
Polyphen
0.010
B;.;.
Vest4
0.038
MPC
0.13
ClinPred
0.0053
T
GERP RS
-4.6
PromoterAI
-0.037
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.082
gMVP
0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6748672; hg19: chr2-71351403; COSMIC: COSV54905236; API